Novus Capital is a leading regional investment banking firm in pharmaceutical industry with geographic focus on Russia, the CIS and the Baltic States. Novus Capital professionals have a broad experience in advising owners and foreign investors in M&A transactions and related activities (due diligence, structuring, negotiations etc.). In recent years our team executed a number of cross border transactions in pharmaceutical industry with total value of USD 450 m, making our team the leading financial adviser to pharmaceutical companies in Russia
| Website | http://www.novuscapital.ru |
| Revenue | $4 million |
| Employees | 13 (13 on RocketReach) |
| Founded | 2015 |
| Address | Federation Tower, Tower West, 41St Fl 12 Presnenskaya Nab, Moscow, Moscow 123100, RU |
| Phone | +7 495 286-72-60 |
| Industry | Investment Banking, Finance |
| Keywords | Financial Analysis, Investment Banking, Strategic Advisory, Mergers And Acquisitions, Financial Advisory, International Finance, Private Equity, Pharmaceutical Investment, Capital Markets, M&A Advisory, Corporate Finance, Deal Making, Investment Management, Wealth Management, Transaction Advisory, Business Valuation, Due Diligence, Financial Modeling, Portfolio Management, Risk Management |
| Competitors | Credit Suisse, Deutsche Bank, J.P. Morgan, Gazprombank, VTB Capital, ATON, Otkritie, REGION Group, Sberbank, Банк Уралсиб +18 more (view full list) |
| SIC | SIC Code 62 Companies |
| NAICS | NAICS Code 5231 Companies, NAICS Code 52311 Companies, NAICS Code 52 Companies, NAICS Code 523 Companies, NAICS Code 523110 Companies |
Looking for a particular Novus Capital employee's phone or email?
The Novus Capital annual revenue was $4 million in 2026.
Aleksandr Lobakov is the Managing Partner of Novus Capital.
13 people are employed at Novus Capital.
Novus Capital is based in Moscow, Moscow.
The NAICS codes for Novus Capital are [5231, 52311, 52, 523, 523110].
The SIC codes for Novus Capital are [62].